• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: New opportunities in drug design for the management and treatment of type 2 diabetes.

作者信息

Rasouli Hassan, Ramalho Teodorico C, Popović-Djordjević Jelena B, Devkota Hari Prasad

机构信息

Medical Biology Research Center (MBRC), Kermanshah University of Medical Sciences, Kermanshah, Iran.

Department of Chemistry, Federal University of Larvas, Larvas, Brazil.

出版信息

Front Pharmacol. 2023 Apr 6;14:1187057. doi: 10.3389/fphar.2023.1187057. eCollection 2023.

DOI:10.3389/fphar.2023.1187057
PMID:37089955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10116046/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eba5/10116046/9b41e3e8e833/fphar-14-1187057-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eba5/10116046/9b41e3e8e833/fphar-14-1187057-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eba5/10116046/9b41e3e8e833/fphar-14-1187057-g001.jpg

相似文献

1
Editorial: New opportunities in drug design for the management and treatment of type 2 diabetes.社论：2型糖尿病管理与治疗药物设计的新机遇
Front Pharmacol. 2023 Apr 6;14:1187057. doi: 10.3389/fphar.2023.1187057. eCollection 2023.
2
Editorial: new treatment of diabetes mellitus.社论：糖尿病的新疗法
Wien Med Wochenschr. 2011 Jun;161(11-12):281. doi: 10.1007/s10354-011-0916-4.
3
Editorial overview: Endocrine and metabolic diseases Druggable diabetes: identification of therapeutic opportunities.社论概述：内分泌和代谢疾病 可药物治疗的糖尿病：治疗机会的识别
Curr Opin Pharmacol. 2018 Dec;43:iii-v. doi: 10.1016/j.coph.2018.10.002. Epub 2018 Nov 13.
4
An editorial on the article 'Patents in the Diabetes Area in the Years 2008-2016'.一篇关于《2008 - 2016年糖尿病领域专利》一文的社论。
Expert Opin Ther Pat. 2018 Mar;28(3):173-174. doi: 10.1080/13543776.2018.1427734. Epub 2018 Jan 15.
5
Evaluation of hypoglycemic therapeutics and nutritional supplementation for type 2 diabetes mellitus management: An insight on molecular approaches.评价 2 型糖尿病管理的降糖治疗和营养补充：分子方法的见解。
Biotechnol Lett. 2022 Feb;44(2):203-238. doi: 10.1007/s10529-022-03232-3. Epub 2022 Feb 4.
6
[Treatment of diabetes mellitus with oral hypoglycemic agents].[口服降糖药治疗糖尿病]
Nihon Rinsho. 2011 Mar;69(3):563-72.
7
Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations.贝达喹啉和地拉米啶在糖尿病患者中的应用：临床及药理学考量
Drug Des Devel Ther. 2016 Dec 7;10:3983-3994. doi: 10.2147/DDDT.S121630. eCollection 2016.
8
Analysis of the characteristics of patients with diabetes mellitus who attend a tertiary hospital emergency department for a hypoglycemic event.对因低血糖事件前往三级医院急诊科就诊的糖尿病患者特征的分析。
Endocrinol Diabetes Nutr (Engl Ed). 2019 Jan;66(1):19-25. doi: 10.1016/j.endinu.2018.06.013. Epub 2018 Aug 29.
9
Cognition and drug adherence to oral hypoglycemic and antihypertensive agents in older adults.老年人对口服降糖药和降压药的认知与药物依从性
Patient Prefer Adherence. 2019 May 30;13:891-899. doi: 10.2147/PPA.S195756. eCollection 2019.
10
Drug-induced hypoglycemic coma in 102 diabetic patients.102例糖尿病患者的药物性低血糖昏迷
Arch Intern Med. 1999 Feb 8;159(3):281-4. doi: 10.1001/archinte.159.3.281.

引用本文的文献

1
Exploring Holy Basil's Bioactive Compounds for T2DM Treatment: Docking and Molecular Dynamics Simulations with Human Omentin-1.探索用于2型糖尿病治疗的圣罗勒生物活性化合物：与人网膜素-1的对接和分子动力学模拟
Cell Biochem Biophys. 2025 Mar;83(1):793-810. doi: 10.1007/s12013-024-01511-6. Epub 2024 Sep 11.

本文引用的文献

1
An update on peptide-based therapies for type 2 diabetes and obesity.关于 2 型糖尿病和肥胖症的基于肽的治疗方法的最新进展。
Peptides. 2023 Mar;161:170939. doi: 10.1016/j.peptides.2023.170939. Epub 2023 Jan 3.
2
Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales.抗糖尿病药物研发趋势：美国食品药品监督管理局批准的药物、临床试验中的新药及全球销售额。
Front Pharmacol. 2022 Jan 19;12:807548. doi: 10.3389/fphar.2021.807548. eCollection 2021.
3
Diabetes and plant-derived natural products: From ethnopharmacological approaches to their potential for modern drug discovery and development.
糖尿病与植物源天然产物：从民族药理学方法到现代药物发现与开发的潜力。
Phytother Res. 2021 Jan;35(1):223-245. doi: 10.1002/ptr.6821. Epub 2020 Sep 9.
4
Anti-diabetic potential of plant alkaloids: Revisiting current findings and future perspectives.植物生物碱的抗糖尿病潜力：重新审视当前的发现和未来的展望。
Pharmacol Res. 2020 May;155:104723. doi: 10.1016/j.phrs.2020.104723. Epub 2020 Feb 24.
5
Omics-based biomarkers in the diagnosis of diabetes.基于组学的生物标志物在糖尿病诊断中的应用
J Basic Clin Physiol Pharmacol. 2019 Nov 14;31(2):/j/jbcpp.2020.31.issue-2/jbcpp-2019-0120/jbcpp-2019-0120.xml. doi: 10.1515/jbcpp-2019-0120.
6
Antidiabetics: Structural Diversity of Molecules with a Common Aim.抗糖尿病药物：具有共同目标的分子的结构多样性。
Curr Med Chem. 2018;25(18):2140-2165. doi: 10.2174/0929867325666171205145309.